Stay updated on GT90001+Nivolumab in Metastatic HCC Clinical Trial
Sign up to get notified when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.

Latest updates to the GT90001+Nivolumab in Metastatic HCC Clinical Trial page
- Check7 days agoChange DetectedThe page shows a new footer revision 'Revision: v3.4.2' and removes the government funding status notice (formerly 'Revision: v3.4.1'). This appears to be a routine site maintenance update with no effect on the study content or results.SummaryDifference0.4%

- Check14 days agoChange DetectedA global banner about government funding and NIH operations was added, with links to cc.nih.gov and opm.gov, and the site revision updated to v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedUI and metadata updates: a glossary display option was added, and the study history now includes 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision indicator updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check57 days agoChange DetectedFooter updates include the addition of Revision: v3.3.3 and the removal of HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded an Auto-PubMed note indicating publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2; removed the older PubMed note and revision v3.2.0.SummaryDifference0.1%

Stay in the know with updates to GT90001+Nivolumab in Metastatic HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.